We are live on ! Find out more
SIP

Stoneridge Investment Partners Portfolio holdings

AUM $152M
1-Year Est. Return 20.58%
This Fund
S&P 500
This Quarter Est. Return
-7.59%
1 Year Est. Return
+20.58%
3 Year Est. Return
+44.17%
5 Year Est. Return
+32.14%
10 Year Est. Return
+92.72%
AUM
$118M
AUM Growth
-$161M
Cap. Flow
-$150M
Cap. Flow %
-126.57%
Top 10 Hldgs %
37.16%
Holding
162
New
27
Increased
6
Reduced
50
Closed
47

Top Buys

Rank Stock Value
1
PNC icon
PNC Financial Services
PNC
+$2.97M
2
BDX icon
Becton Dickinson
BDX
+$2.9M
3
HUM icon
Humana
HUM
+$2.71M
4
ROST icon
Ross Stores
ROST
+$2.4M
5
AIZ icon
Assurant
AIZ
+$1.83M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$10.8M
2
AAPL icon
Apple
AAPL
+$9.54M
3
CVS icon
CVS Health
CVS
+$9.32M
4
NVDA icon
NVIDIA
NVDA
+$8.97M
5
CB icon
Chubb
CB
+$7.65M

Sector Composition

Rank Sector Weight
1 Technology 32.77%
2 Financials 12.97%
3 Healthcare 10.55%
4 Industrials 9.02%
5 Consumer Discretionary 8.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SVCO
101
Silvaco Group
SVCO
$252M
$77K 0.07%
+16,943
New +$116K
EGAN icon
102
eGain
EGAN
$203M
$70K 0.06%
14,409
SGMT icon
103
Sagimet Biosciences
SGMT
$590M
$68K 0.06%
20,836
DFTX
104
Definium Therapeutics
DFTX
$5.46B
$63K 0.05%
10,759
TERN
105
DELISTED
Terns Pharmaceuticals
TERN
$57K 0.05%
20,603
NB
106
NioCorp Developments
NB
$788M
$54K 0.05%
27,219
VGAS icon
107
Verde Clean Fuels
VGAS
$28.4M
$51K 0.04%
15,307
HCAT icon
108
Health Catalyst
HCAT
$136M
$49K 0.04%
10,893
STKS icon
109
The ONE Group
STKS
$56.5M
$44K 0.04%
14,574
SGHT icon
110
Sight Sciences
SGHT
$441M
$37K 0.03%
15,235
APPS icon
111
Digital Turbine
APPS
$1.6B
$36K 0.03%
13,301
SEAT icon
112
Vivid Seats
SEAT
$84.9M
$34K 0.03%
576
CIFR icon
113
Cipher Digital
CIFR
$7.16B
$29K 0.02%
+12,680
New +$57.7K
GUTS icon
114
Fractyl Health
GUTS
$109M
$26K 0.02%
21,618
LCTX icon
115
Lineage Cell Therapeutics
LCTX
$278M
$5K ﹤0.01%
10,712
AIG icon
116
American International
AIG
$40.6B
-63,377
Closed -$4.61M
ALLY icon
117
Ally Financial
ALLY
$13.4B
-62,822
Closed -$2.26M
BMRN icon
118
BioMarin Pharmaceuticals
BMRN
$13.5B
-10,545
Closed -$693K
CB icon
119
Chubb
CB
$134B
-27,680
Closed -$7.65M
CEG icon
120
Constellation Energy
CEG
$98.7B
-3,321
Closed -$743K
CHKP icon
121
Check Point Software Technologies
CHKP
$13.2B
-4,287
Closed -$800K
CI icon
122
Cigna
CI
$72B
-949
Closed -$262K
CTVA icon
123
Corteva
CTVA
$51.2B
-47,309
Closed -$2.69M
CVS icon
124
CVS Health
CVS
$119B
-207,651
Closed -$9.32M
DAL icon
125
Delta Air Lines
DAL
$59.7B
-21,889
Closed -$1.32M

Similar funds

Stoneridge Investment Partners's Q1 2025 Portfolio in Review

As of Q1 2025, Stoneridge Investment Partners held 162 positions worth $118M, down 58% from $280M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Stoneridge Investment Partners withdrew a net $150M in Q1 2025, closing 47 positions and reducing 50 holdings. Its most notable exit was CVS Health, an estimated $9.32M position sold in full.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 37% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Stoneridge Investment Partners opened a new position in Becton Dickinson worth $2.86M.

  • Stoneridge Investment Partners's largest Q1 2025 buy was Becton Dickinson: 12,485 shares worth $2.86M.
  • Stoneridge Investment Partners added most to PNC Financial Services in Q1 2025, an estimated $2.97M increase.
  • Stoneridge Investment Partners's biggest Q1 2025 reduction was Microsoft, cutting an estimated $10.8M.
  • Stoneridge Investment Partners fully exited CVS Health in Q1 2025, selling an estimated $9.32M.
  • Stoneridge Investment Partners's ten largest holdings make up 37% of its $118M portfolio in Q1 2025.
  • Stoneridge Investment Partners opened 27 new positions and closed 47 in Q1 2025.
  • Stoneridge Investment Partners's portfolio value fell 58% quarter-over-quarter to $118M.

Based on Stoneridge Investment Partners's 13F filing for Q1 2025, filed 14 May 2025.